Soros Partners Llc Perseus, 10% Owner at MAP Pharmaceuticals, Inc. (MAPP), sold 5,293 shares at $13.95 ($74K) on 2010-03-05, disclosed to the SEC on 2010-03-08.
Open-market sale of $74k MAPP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.15 | 677 | $10K | 13.0% |
| 2 | $13.95 | 4,616 | $64K | 87.0% |
| Total | $13.98 avg | 5,293 | $74K | 100% |